Evidence map›Paper›PMID 39069199›Full record

ArticleThe American journal of medicine2025

Internal Tremors and Vibrations in Long COVID: A Cross-Sectional Study.

Tianna Zhou, Mitsuaki Sawano, Adith S Arun, César Caraballo, Teresa Michelsen, Lindsay S McAlpine, Bornali Bhattacharjee, Yuan Lu, Rohan Khera, Chenxi Huang and 4 more

Abstract read
In one paragraph

Article in The American journal of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Ocular Symptoms in Long COVID: A Cross-Sectional Study.Clinical ophthalmology (Auckland, N.Z.) · 2026
    Article
  2. Neuroimmune pathophysiology of long COVID.Psychiatry and clinical neurosciences · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Tianna ZhouYale School of Medicine, New Haven, Conn.
Mitsuaki SawanoCenter for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Conn; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Conn.
Adith S ArunYale School of Medicine, New Haven, Conn.
César CaraballoCenter for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Conn; Department of Internal Medicine, Yale School of Medicine, New Haven, Conn.
Teresa MichelsenAvocet Consulting LLC, Hoodsport, WA.
Lindsay S McAlpineDepartment of Neurology, Yale School of Medicine, New Haven, Conn.
Bornali BhattacharjeeDepartment of Immunobiology, Yale School of Medicine, New Haven, Conn; Center for Infection and Immunity, Yale School of Medicine, New Haven, Conn.
Yuan LuCenter for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Conn; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Conn.
Rohan KheraCenter for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Conn; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Conn; Section of Health Informatics, Department of Biostatistics, Yale School of Public Health, New Haven, Conn.
Chenxi HuangCenter for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Conn; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Conn.
Frederick WarnerCenter for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Conn; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Conn.
Jeph HerrinSection of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Conn.
Akiko IwasakiDepartment of Immunobiology, Yale School of Medicine, New Haven, Conn; Center for Infection and Immunity, Yale School of Medicine, New Haven, Conn; Howard Hughes Medical Institute, Chevy Chase, Md.
Harlan M KrumholzCenter for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, Conn; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Conn; Center for Infection and Immunity, Yale School of Medicine, New Haven, Conn; Department of Health Policy and Management, Yale School of Public Health, New Haven, Conn. Electronic address: harlan.krumholz@yale.edu.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Short-Term Reserch Training: Students in Health SchoolsT35HL007649 · NHLBI · YALE UNIVERSITY · PI Sarwat I Chaudhry, Erica L Herzog · 1987 to 2026
$5.7M
Evaluating and Improving Utilization of Evidence-Based Medical Therapy in Patients with Heart Failure using Automated Tools in the Electronic Health RecordK23HL153775 · NHLBI · YALE UNIVERSITY · PI KHERA, ROHAN · 2021 to 2025
$918k
Magnetic Resonance Imaging Biomarkers of Post-COVID-19 Cerebral Microvascular DysfunctionK23NS133488 · NINDS · YALE UNIVERSITY · PI Lindsay Sarah McAlpine · 2024 to 2026
$695k
FDA HHS U01 FD005938NCATS NIH HHS UL1 TR001863NHLBI NIH HHS K23 HL153775NHLBI NIH HHS T35 HL007649NINDS NIH HHS K23 NS133488
6 · The paper itself

Abstract

backgroundInternal tremors and vibrations are symptoms previously described as part of neurologic disorders but not fully described as a part of long COVID. This study compared pre-pandemic comorbidities, new-onset conditions, and long COVID symptoms between people with internal tremors and vibrations as part of their long COVID symptoms and people with long COVID but without these symptoms.

methodsThe Yale Listen to Immune, Symptom and Treatment Experiences Now (LISTEN) Study surveyed 423 adults who had long COVID between May 12, 2022 and June 1, 2023. The exposure variable was long COVID symptoms of internal tremors and vibrations. The outcome variables were demographic characteristics, pre-pandemic comorbidities, new-onset conditions, other symptoms, and quality of life.

resultsAmong study participants with long COVID, median age was 46 years (IQR, 38-56), 74% were female, 87% were Non-Hispanic White, and 158 (37%) reported "internal tremors, or buzzing/vibration" as a long COVID symptom. The two groups reported similar pre-pandemic comorbidities, but participants with internal tremors reported worse health as measured by the Euro-QoL visual analogue scale (median: 40 points [IQR, 30-60] vs. 50 points [IQR, 35-62], P = .007) and had higher rates of new-onset mast cell disorders (11% [95% CI, 7.1-18] vs. 2.6% [1.2-5.6], P = .008) and neurologic conditions (22% [95% CI, 16-29] vs. 8.3% [5.4-12], P = .004).

conclusionsAmong people with long COVID, those with internal tremors and vibrations had different conditions and symptoms and worse health status compared with others who had long COVID without these symptoms.

Indexed as

COVID-19TremorVibrationAdultComorbidityCross-Sectional StudiesFemaleHumansMaleMiddle AgedPost-Acute COVID-19 SyndromeQuality of LifeSARS-CoV-2COVID-19Long COVIDNeurologicTremorVibration

Identifiers

PMID39069199
PMCPMC12023347

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.